alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### National Oceanic and Atompsheric Administration

# AGENCY:

National Marine Sanctuary Program (NMSP), National Ocean Service (NOS), National Oceanic and Atmospheric Administration (NOAA), Department of Commerce (DOC).

# ACTION:

Extension of application deadline. 

# SUMMARY:

The Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHMWNMS) is extending the deadline for applications for both primary and alternate members of the following seats on its Sanctuary Advisory Council (Council): Education, Fishing, Hawaii County, Honolulu County, Kauai County, Maui County, Native Hawaiian, and Research. The original notice was published on August 10, 2005, (Volume 70, Number 153) [Notices] [Page 46492].

# DATES:

Applications are due by November 15, 2005.

# ADDRESSES:

                        Application packets may be obtained from Keeley Belva (888) 55-WHALE or via e-mail at:                         *Keeley. Belva@noaa.gov.*                         Applications are also available on line at                         *http://hawaiihumpbackwhale.noaa.gov.*                         Completed applications should be mailed to Keeley Belva, Hawaiian Islands Humpback Whale National Marine Sanctuary, 6600 Kalaniana'ole Highway, Suite 301, Honolulu Hawai'i 96825, faxed to (808) 397-2650, or returned via e-mail.                    

# FOR FURTHER INFORMATION CONTACT:

Keeley Belva (see above for contact information).

Authority:16 U.S.C. Section 1431*et seq.*

(Federal Domestic Assistance Catalog Number 11.429 Marine Sanctuary Program)

Dated: October 19, 2005.

Daniel J. Basta,

Director, National Marine Sanctuary Program, National Ocean Service, National Oceanic and Atmospheric Administration.

[FR Doc. 05-21441 Filed 10-26-05; 8:45 am]

BILLING CODE 3510-NK-M
United States Department of Labor

Employees’ Compensation Appeals Board

__________________________________________

D.B., Appellant

and

DEPARTMENT OF THE ARMY, ABERDEEN 

PROVING GROUND, Aberdeen, MD, Employer

__________________________________________

)

)

)

)

)

)

)

)

Docket No. 21-0195

Issued: October 27, 2021

Appearances: Case Submitted on the Record

Appellant, pro se

Office of Solicitor, for the Director

ORDER REMANDING CASE

Before:

ALEC J. KOROMILAS, Chief Judge

PATRICIA H. FITZGERALD, Alternate Judge

VALERIE D. EVANS-HARRELL, Alternate Judge

On November 16, 2020 appellant filed a timely appeal from a September 15, 2020 merit 

decision of the Office of Workers’ Compensation Programs (OWCP). The Clerk of the Appellate 

Board’s assigned Docket No. 21-0195.

In the September 15, 2020 decision, OWCP denied modification of its February 5 and 

October 15, 2019 decisions which denied appellant’s May 24, 2016 traumatic injury claim (Form 

CA-1) for injuries to her left knee and back. 

In its prior decisions, OWCP referenced appellant’s April 20, 2016 occupational disease 

claim (Form CA-2) under OWCP File No. xxxxxx723, which also alleged back and left knee 

conditions. OWCP noted that the prior claim involved the back and left knee, and that the claim 

had been denied based on the medical evidence. It also noted that appellant indicated that she had 

initially filed an occupational disease claim because her employing establishment liaison advised 

her to do so, but she later understood that she should have filed a traumatic injury claim. 

Having duly considered this matter, the Board finds that the case is not in posture for a 

decision. Under its procedures, OWCP has determined that cases should be administratively 

combined when correct adjudication of the issues depends on frequent cross-referencing between 
2

files.1 OWCP’s procedures further provide for doubling of a claim when a new injury case is 

reported for an employee who previously filed a claim for a similar condition or the same part of 

the body.

2

 

Therefore, for a full and fair adjudication, the case will be remanded to OWCP to

administratively combine the present claim with File No. xxxxxx723. Following this and such 

other such further development as deemed necessary, OWCP shall issue a de novo decision 

regarding appellant’s traumatic injury claim.

IT IS HEREBY ORDERED THAT the September 15, 2020 decision of the Office of 

Workers’ Compensation Programs is set aside and the case is remanded for further proceedings 

consistent with this order of the Board.

Issued: October 27, 2021

Washington, DC

Alec J. Koromilas, Chief Judge

Employees’ Compensation Appeals Board

Patricia H. Fitzgerald, Alternate Judge

Employees’ Compensation Appeals Board

Valerie D. Evans-Harrell, Alternate Judge

Employees’ Compensation Appeals Board

1 Federal (FECA) Procedure Manual, Part 2 -- Claims, File Maintenance and Management, Chapter 2.400.8(c) 

(September 2011).

2

Id. at Chapter 2.400.8(c)(1)-(2).
<PAGE>

EXHIBIT 32


                                  CERTIFICATION
                                       OF
                             CHIEF EXECUTIVE OFFICER
                                       AND
                             CHIEF FINANCIAL OFFICER
                           PURSUANT TO 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         I, Stephen Tang, certify, pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report on Form 10-QSB of Financial Telecom Limited (USA), Inc. for the quarter
ended September 30, 2004 (the "Report"), as filed with the Securities and
Exchange Commission on the date hereof, to the best of my knowledge and belief:

         (1) the Report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

         (2) the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.

                        By: /s/ Stephen Tang
                            ---------------------------------------------------
                            Stephen Tang
                            Chief Executive Officer and Chief Financial Officer
                            (Principal Executive and Financial Officer)

                            Date: November 12, 2004
<PAGE>

                                                                    Exhibit 10.5


Innovative Drug Delivery Systems, Inc.
September 22, 2000

CONFIDENTiAL

Dr. Donald B. Morel Sr,, Division President
West Pharmaceutical Services, Inc.
101 Gordon Drive
Lionville, PA 19341


Re: Letter Agreement


Dear Don:

This letter shall serve as our agreement that Section 4.1 of the License
Agreement between West Pharmaceutical Services, Inc., its wholly owned
subsidiary West Pharmaceutical Services Drug Delivery & Clinical Research Centre
Ltd. and Innovative Drug Delivery Systems, Inc. is hereby amended in its
entirety to read as follows:

4.1 License Fees. IDDS shall pay to West the amount of $2,250,000 on or before
September 27, 2000.

If this is acceptable to you, kindly execute this Letter Agreement where
appropriate and return a copy to me at your earliest convenience.

Thank you.


                                    Sincerely,



                                    Mark C. Rogers, M.D.
                                    Chairman


WEST PHARMACEUTICAL SERVICES, INC.

By:  /s/ Donald E. Morel Jr.
   ----------------------------------------------
         Donald E. Morel Jr., Division President,
         Drug Delivery Systems


WEST PHARMACEUTICAL SERVICES DRUG DELIVERY &
CLINICAL RESEARCH CENTRE LTD.

By:  /s/ Donald E. Morel Jr., Chairman
   ----------------------------------------------
         Donald E. Morel Jr., Chairman

                       787 Seventh Avenue 48th Floor New York, NY 10019
                        Tel: 212-554-4351 Fax: 212-554-4490
111TH CONGRESS 

2D SESSION H. R. 5307 

AN ACT 

To amend the Tariff Act of 1930 to include ultralight vehicles under the definition of aircraft for purposes of the 

aviation smuggling provisions under that Act. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 5307 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may cited as the ‘‘Ultralight Smuggling Pre3 vention Act of 2010’’. 

4 SEC. 2. DEFINITION OF AIRCRAFT UNDER AVIATION SMUG5 GLING PROVISIONS OF THE TARIFF ACT OF 

6 1930. 

7 (a) IN GENERAL.—Section 590 of the Tariff Act of 

8 1930 (19 U.S.C. 1590) is amended— 

9 (1) by redesignating subsection (g) as sub10 section (h); and 

11 (2) by inserting after subsection (f) the fol12 lowing: 

13 ‘‘(g) DEFINITION OF AIRCRAFT.—As used in this sec14 tion, the term ‘aircraft’ includes an ultralight vehicle, as 

15 defined by the Administrator of the Federal Aviation Ad16 ministration.’’. 

17 (b) EFFECTIVE DATE.—The amendments made by 

18 subsection (a) apply with respect to violations of any pro19 vision of section 590 of the Tariff Act of 1930 on or after 

20 the 30th day after the date of the enactment of this Act. 

21 SEC. 3. PAYGO COMPLIANCE. 

22 The budgetary effects of this Act, for the purpose of 

23 complying with the Statutory Pay-As-You-Go Act of 2010, 

24 shall be determined by reference to the latest statement 

25 titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 

26 Act, submitted for printing in the Congressional Record 
3 

•HR 5307 EH

1 by the Chairman of the House Budget Committee, pro2 vided that such statement has been submitted prior to the 

3 vote on passage. 

Passed the House of Representatives September 23, 

2010. 

Attest: 

Clerk. 
111TH CONGRESS 

2D SESSION H. R. 5307 

AN ACT 

To amend the Tariff Act of 1930 to include ultraunder that Act. purposes of the aviation smuggling provisions light vehicles under the definition of aircraft for
I 

111TH CONGRESS 

2D SESSION H. R. 5311 

To amend the Internal Revenue Code of 1986 to make permanent the treatment of municipal bonds guaranteed by Federal home loan banks as 

tax exempt bonds. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 13, 2010 

Mr. PASCRELL (for himself, Mr. BOUSTANY, and Mr. KANJORSKI) introduced 

the following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to make 

permanent the treatment of municipal bonds guaranteed 

by Federal home loan banks as tax exempt bonds. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Community Develop5 ment Financing Act of 2010’’. 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•HR 5311 IH

1 SEC. 2. TREATMENT OF MUNICIPAL BONDS GUARANTEED 

2 BY FEDERAL HOME LOAN BANKS AS TAX EX3 EMPT BONDS MADE PERMANENT. 

4 Clause (iv) of section 149(b)(3)(A) of the Internal 

5 Revenue Code of 1986 is amended by striking ‘‘during the 

6 period beginning on the date of the enactment of this 

7 clause and ending on December 31, 2010’’ and inserting 

8 ‘‘on or after July 30, 2008’’. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
NOT FOR PUBLICATION IN WEST'S HAWAI I REPORTS AND PACIFIC REPORTER

NO. CAAP-21-0000481

IN THE INTERMEDIATE COURT OF APPEALS
OF THE STATE OF HAWAI I
SCOTT BUKOSKI, Plaintiff-Appellee, v. JULIA J. WHEELER, Defendant-Appellant.

APPEAL FROM THE DISTRICT COURT OF THE THIRD CIRCUIT

PUNA DIVISION (REPORT NO. 3DRC-21-0001064)

ORDER DISMISSING APPEAL (By: Ginoza, Chief Judge, Leonard and McCullen, JJ.) Upon review of the record, it appears that: (1) The statement of jurisdiction and opening brief were due on or before October 18, 2021, and November 15, 2021, respectively;

(2) Self-represented Defendant-Appellant Julia J. Wheeler (Wheeler) failed to file either document or request an extension of time;

(3) On November 22, 2021, the appellate clerk entered a default notice informing Wheeler that the time for filing the statement of jurisdiction and opening brief had expired, the matter would be called to the court's attention on December 2, 2021, for appropriate action, which could include dismissal of the appeal, under Hawai i Rules of Appellate Procedure (HRAP) Rules 12.1(e) and 30, and Wheeler could request relief from default by motion;

(4) The appellate clerk mailed the notice of entering case on calendar and the default notice to Wheeler at her address on record. The United States Postal Service did not return the Electronically Filed Intermediate Court of Appeals CAAP-21-0000481 20-APR-2022 08:07 AM Dkt. 24 ODSDNOT FOR PUBLICATION IN WEST'S HAWAI I REPORTS AND PACIFIC REPORTER

notice of entering case on calendar but returned the default notice as "unclaimed" and "unable to forward"; and

(5) Wheeler has not filed a notice of change of address, consistent with HRAP Rule 25(f), or taken any further action in this appeal since filing the notice of appeal.

Therefore, IT IS HEREBY ORDERED that the appeal is dismissed. DATED: Honolulu, Hawai i, April 20, 2022. /s/ Lisa M. Ginoza Chief Judge /s/ Katherine G. Leonard Associate Judge /s/ Sonja M.P. McCullen Associate Judge

2
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                                   AS ADDED BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

   In connection with the Quarterly Report of OptimumBank Holdings, Inc. (the
"Company") on Form 10-QSB for the period ended September 30, 2004 as filed with
the Securities and Exchange Commission (the "Report"), I, Richard L. Browdy,
Chief Financial Officer (Principal Accounting Officer) of the Company, certify,
pursuant to 18 U.S.C.ss. 1350, as added by ss. 906 of the Sarbanes-Oxley Act of
2002, that:

1.       The Report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

2.       To my knowledge, the information contained in the Report fairly
         presents, in all material respects, the financial condition and results
         of operations of the Company as of and for the period covered by the
         report.

Date:  November 15, 2004         By: /s/Richard L. Browdy
       -----------------             --------------------
                                     Richard L. Browdy, Chief Financial Officer
<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                          81,291
<SECURITIES>                                         0
<RECEIVABLES>                                4,119,357
<ALLOWANCES>                                    45,000
<INVENTORY>                                  3,315,093
<CURRENT-ASSETS>                             7,667,787
<PP&E>                                       3,652,943
<DEPRECIATION>                               1,402,327
<TOTAL-ASSETS>                              67,851,369
<CURRENT-LIABILITIES>                        3,678,229
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       223,247
<OTHER-SE>                                  28,094,850
<TOTAL-LIABILITY-AND-EQUITY>                67,851,369
<SALES>                                     23,810,276
<TOTAL-REVENUES>                            24,654,666
<CGS>                                       17,169,915
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,567,798
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,123,856
<INCOME-PRETAX>                              8,157,768
<INCOME-TAX>                                 4,011,749
<INCOME-CONTINUING>                          5,877,122
<DISCONTINUED>                                       0
<EXTRAORDINARY>                              (295,322)
<CHANGES>                                    (274,248)
<NET-INCOME>                                 5,307,552
<EPS-PRIMARY>                                      .23
<EPS-DILUTED>                                      .23
        


</TABLE>
Exhibit 32.2

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Gramercy Capital Corp. (the "Company") on Form 10-Q as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Robert R. Foley, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

|/s/ROBERT R. FOLEY |                         | 
|------------------ | ----------------------- | 
|Name:              | Robert R. Foley         | 
|Title:             | Chief Financial Officer | 

November
9, 2007

---



QuickLinks
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel. Review of Research Program Projects (P01s).                    

*Date:*                         November 22, 2005.                    

*Time:*                         9 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         NIAMS Institute, One Democracy Plaza, 6701 Democracy, Suite 800, Bethesda, MD 20892.                    

*Contact Person:*                         Yan Z Wang, PhD, MD, Scientific Review Administrator, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701 Democracy Blvd., Suite 820, Bethesda, MD 20892, (301) 594-4957,                         *wangy1@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)

Dated: October 20, 2005.

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-21664  Filed 10-31-05; 8:45 am]

BILLING CODE 4140-01-M
Exhibit
32.1




CERTIFICATION PURSUANT TO 18
U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002




In
connection with the Annual Report of Implant Sciences Corporation., a
Massachusetts corporation (the “Company”), on Form 10-K/A for the fiscal year
ended June 30, 2008, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Phillip C. Thomas, Chief Executive Officer and
President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge:




(1)                The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2)                The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.




/s/
      Phillip C. ThomasPhillip
      C. ThomasChief
      Executive Officer and PresidentDate:
      October 29, 2008







This
certification accompanies each report of the Company on Form 10-Q and Form 10-K
pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the
extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the
Company for purposes of §18 of the Securities Exchange Act of 1934, as
amended.




A signed
original of this written statement required by §906 has been provided to the
Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.
Exhibit 32.2



CERTIFICATION PURSUANT TO 18 U. S. C. SECTION 1350,

AS ADOPTED, PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



The undersigned executive officer of the registrant hereby certifies that this Form 10-K
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained herein fairly presents, in all material respects, the financial condition and results of operations of the
registrant.



|                       
|-----------------------
|/s/ Paul S. Musgrove   
|Paul S. Musgrove       
|Chief Financial Officer



Date: September 9, 2005